Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach. (2021)
Attributed to:
Clinical, genetic and immune determinants of drug immunogenicity in psoriasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/jdv.16980
PubMed Identifier: 33030275
Publication URI: http://europepmc.org/abstract/MED/33030275
Type: Journal Article/Review
Volume: 35
Parent Publication: Journal of the European Academy of Dermatology and Venereology : JEADV
Issue: 2
ISSN: 0926-9959